Osler PodcastsCOVID podcasts
In these unprecedented times, it is critical to get the latest information to clinicians about COVID-19.15 clip(s)
Vaccine induced thrombotic thrombocytopenia28:33
Covid nutrition23:16
SPRINT SARI - an update08:05
Long term outcomes from COVID17:15
Lise Estcourt - convalescent plasma in COVID 1913:07
Colin McArthur - REMAP-CAP steroids31:30
Tony Gordon - convalescent serum for COVID-1913:00
Colin McArthur - Hydroxychloroquine in COVID-1918:22
Mark Nichols - ANZICS COVID19 guidelines update19:26
Steve Warrilow - complex decision making26:21
David Brewster - intubation for COVID-1922:11
Steve Webb - REMAP-CAP17:47
Aidan Burrell - SPRINT SARI07:30
As the COVID-19 pandemic surges ahead, researchers are desperately seeking evidence to support a range of potential disease modifying treatments.
On this episode, Prof Tony Gordon from Imperial Hospitals in London joins me to discuss one such potential therapy, convalescent serum. Tony is a prominent intensivist researcher and is the UK chief investigator for the REMAP-CAP study.
